Could a simple dye replace painful stents in endometriosis surgery?

NCT ID NCT06852248

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 37 times

Summary

This pilot study tests whether using a dye (indocyanine green) to see the ureters during endometriosis surgery causes less pain than the usual method of placing temporary plastic stents. About 70 women aged 18-50 having deep endometriosis surgery will take part. The goal is to see if this dye method is feasible and acceptable before a larger trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospitals of North Midlands NHS Trust

    RECRUITING

    Stoke-on-Trent, Staffordshire, ST4 6QG, United Kingdom

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Indocyanine green (ICG) dye

What this could lead to

If this approach works, it could offer a less painful alternative to ureteric stents during endometriosis surgery, reducing recovery discomfort.

What could go wrong

This is a small pilot study with only 70 participants, so results may not apply widely. The dye method might not be as effective at preventing ureter damage as stenting.

Conditions

The condition(s) this trial relates to.

endometriosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.